STAT
AUGUST 3, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
PharmaTech
AUGUST 3, 2024
Will Sanofi’s plan to recruit the younger generation through its participation in the upcoming 2024 Olympic and Paralympic Games, being held in Paris, pay off?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GMPSOP
AUGUST 3, 2024
Free Spins No Deposit Casinos Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Content How Do I Claim Free Spins? Pokerstars Bonus Code Marz 2022 How Would You Like To Play 100 Free Spins Every Single Day? Au Deposit 25 Get 100, 30fs The Hottest Christmas Experience With Cadabrus Casino You will often find that you are limited on the slots you can play on.
PharmaTech
AUGUST 3, 2024
Potential conflicts of interest with advisory group members have led to EMA’s impartiality coming into questioned for some marketing authorization decisions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
AUGUST 3, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim a
PharmaTech
AUGUST 3, 2024
This acquisition gives AbbVie clinical-stage assets from Cerevel’s pipeline that complement AbbVie's emerging neuroscience pipeline and branded products for treating psychiatric disorders, migraine, and Parkinson's disease.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
AUGUST 3, 2024
This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization.
Pharmacy Times
AUGUST 3, 2024
Investigators determine the efficacy and safety of the combination in a 2-phase trial.
Expert insights. Personalized for you.
248 
Let's personalize your content